Seedcamp is Europe's seed fund, identifying and investing early in world-class founders attacking large, global markets and solving real problems using technology. The Seedcamp Nation includes over 400 startups building breakout businesses that change the way people live, interact and buy and includes publicly listed UiPath, Wise, and unicorns Revolut, Hopin, Sorare, Pleo, and wefox along with fast-growing businesses such as Grover, viz.ai and Ezra.  Seedcamp fast-tracks a founder's vision and creates value through immediate access to smart capital, a lifelong community of support and a global network built upon more than a decade's experience backing exceptional talent. Seedcamp fast-tracks a founder's vision and creates value through immediate access to smart capital, a lifelong community of support, and a global network built upon more than a decade's experience backing exceptional talent.

Seedcamp

500 Global is a multi-stage venture capital firm with $2.4 billion in assets under management. The firm invests in founders who are building fast-growing technology companies. It focuses on markets where technology, innovation, and capital can generate long-term value and economic growth. 500 Global collaborates with key stakeholders and provides advisory services to governments on fostering entrepreneurial ecosystems to support startups. The firm has invested in over 5,000 founders and more than 2,800 companies across 80+ countries. It has funded over 35 companies valued at more than $1 billion and over 160 companies valued at over $100 million, including those that are private, public, or have exited. The team consists of over 190 members based in more than 25 countries, with experience as entrepreneurs, investors, and operators from leading technology companies.

500 Global

Redbus invests in early-stage ventures, predominantly but not exclusively, in the UK. Redbus allocates part of its resources to special situations such as acquiring a business that requires reorganising or purchasing an asset that seems materially undervalued. We are not a fund, we are permanent capital, so we invest for the long term and can be very patient. As entrepreneurs ourselves, we understand some great businesses can take time to flourish. Most importantly, we get, like and understand mavericks, innovators and operators. We once were them. We are proven entrepreneurs who are passionate about backing the next generation of entrepreneurs. Our lead people have founded or had senior managerial roles in start-ups that have had successful and material exits. Our portfolio companies benefit from the support both financially and otherwise of experienced entrepreneurs who have been on the same journey they are on. We aim to provide entrepreneurial insights, know-how, strategic introductions and operational experience that will help entrepreneurs have the courage to grab opportunities, avoid some mistakes and ultimately build excellent companies. We love it when people who want to talk to us manage to find someone in our eco-system who can introduce them to us. A recommendation goes a long way. If that is not possible then we would want know why you think we would be the right investors for you as opposed to any one of the other great investors out there. We can move quickly and can run at an entrepreneur's speed. Sometimes we take down a whole round, other times we act as lead and others we just participate. We like investing alongside angel investors whom have proven entrepreneurial experience and successful track record of backing brilliant entrepreneurs.

Redbus Ventures

The stated aim of LCIF is not to fund London tech businesses that otherwise would not get funded but rather to enable those who can raise, to raise significantly more so that they have a sufficient money, time and resources to prove their business model. This way London based tech startups will be more able to raise their next round of funding and thereafter become the great tech companies that London so wants and requires. The London Co-Investment Fund was launched by the Deputy Mayor of London on the 4th December at City Hall. LCIF six co-investment partners has been selected based on their excellent track records of investing and supporting early stage tech businesses in London.

London Co-Investment Fund

Pembroke VCT PLC is a venture capital trust specializing in investments in any stage of business development. Their focus is on companies in the health and fitness, hospitality, apparel, and accessories, and media and technology sectors.

Pembroke VCT

The Guinness Ventures team have been investing in early-stage businesses since 2010. Guinness EIS provides scale-up capital to private companies and Guinness AIM EIS invests in AIM-listed companies. We invest in outstanding entrepreneurs and businesses with disruptive and ambitious growth plans. We have successfully supported the growth of over 100 companies since 2010 and are always excited to meet passionate entrepreneurs.

Guinness Ventures

Target Global is a prominent European technology investment firm with a significant presence in the venture capital landscape, boasting over €3 billion in assets under management.  The firm operates out of key tech hubs including London, Berlin, Tel Aviv, and Abu Dhabi, and has a rich portfolio featuring some of Europe's most successful tech companies such as Revolut, Auto1, Copper, Delivery Hero, Docplanner, and Rapyd. Founding and Growth Target Global was established in 2015 by Shmuel Chafets and Yaron Valler, who brought a wealth of experience from their tenure at Hasso Plattner Ventures. Their professional partnership dates back 15 years to their time at Giza Venture Capital, a trailblazer in Israel's investment ecosystem, where they honed their investment acumen and industry foresight. Investment Philosophy and Impact Target Global stands out in the European tech industry for its diverse team and its ability to identify and capitalize on unique opportunities. The firm's knack for recognizing potential in the early stages of Germany's tech economy led to the emergence of several unicorns in the 2010s. As the European tech industry evolves, Target Global remains at the forefront, seeking out innovative companies like Robovision, Saleor, and Finom. These recent investments reflect the firm's commitment to supporting cutting-edge technology and business models. Fundraising Successes Target Global's fundraising prowess is evident in its six investment funds, which have collectively raised significant capital. The funds range from Early Stage Funds, focusing on nascent startups, to Growth Funds that support more mature companies scaling their operations. The firm's co-investment strategy has led to over €1 billion in capital deployment across a diverse array of partnerships. Backing and Achievements With the backing of investors such as FERI, UBS, Allianz X, Mubadala, and Hermes GPE, Target Global has cemented its reputation as a trusted and successful investment firm. Its portfolio spans over 140 companies at various development stages, with a focus on those targeting trillion-dollar markets. Just a few of the many notable companies in the firm’s portfolio include: - Tarabut, MENA’s leading open banking platform, which was recently featured in Forbes Middle East’s list of Top 50 Fintech Companies. - Flo Health, an AI-driven women’s health product, which is the world’s top health and fitness app by downloads. - Robovision, an easy-to-use AI-driven computer vision platform for users to develop their own deep-learning-based solutions. - Enter, a German company that helps homeowners and businesses reduce their carbon footprint. Target Global's track record includes support for 15 unicorn companies, over 20 exits, and 7 IPOs, showcasing its ability to drive growth and success in the European tech ecosystem. The team, comprised of individuals with founder and operator backgrounds, continues to pursue exceptional opportunities to expand the firm's portfolio and influence. Target Global's journey from its inception to its current status as a key player in European venture capital is marked by strategic investments, a commitment to diversity, and a deep understanding of the tech industry's dynamics. With a clear vision for the future, Target Global is poised to continue its role in shaping the next wave of European tech giants.

Target Global

Thriva

Thriva offers a personalized at-home finger-prick blood test which enables individuals to easily track and improve health. All tests are analyzed by their partner laboratory and results are reviewed by their in-house Doctor (a qualified GP of 7 years). Thriva also helps users understand what they need to focus on to make improvements. It was founded in 2015.

Thriva is a London-based digital health company founded in 2015 by Hamish Grierson, Eliot Brooks, and Tom Livesey. The company offers at-home blood testing kits and a digital platform that allows users to monitor various aspects of their health over time. Thriva's tests cover a range of health markers including cholesterol, liver function, vitamins, hormones, and more. Users receive their test kits by mail, collect a blood sample via finger prick, and return the sample for analysis. Results are typically available within 48 hours through Thriva's online platform, which provides personalized insights and recommendations from doctors.

The at-home health tests worth investing in – and the ones that aren't

Thriva Review: Is This Blood Test Subscription Actually Worth It?

Must Read This Before Buying

Thriva: Get to know the startup normalising at-home blood testing

Thriva Home Blood Test Kit – My Full Review After 3rd Time Using

Read Customer Service Reviews of thriva.co

Superdrug launches blood test service at £179 price point

15 Health Tech London Startups to Watch

Blood Testing Frequently Asked Questions

Thriva Solutions teams up with LloydsPharmacy Online Doctor

Thriva expands blood testing offering to include multichannel collection

Redefining hospital care with the comfort of home

Hospital-at-Home

Thriva Becomes a CQC Registered Company as it Launches Membership Model Thriva+

Thriva is a London-based digital health company founded in 2015 by Hamish Grierson, Eliot Brooks, and Tom Livesey. The company offers at-home blood testing kits and a digital platform that allows users to monitor various aspects of their health over time. Thriva's tests cover a range of health markers including cholesterol, liver function, vitamins, hormones, and more. Users receive their test kits by mail, collect a blood sample via finger prick, and return the sample for analysis. Results are typically available within 48 hours through Thriva's online platform, which provides personalized insights and recommendations from doctors.
Thriva's platform analyzes over 50 biomarkers and provides users with detailed explanations of each marker, its function, and what can cause changes. The company works with UKAS-accredited labs and uses CE-marked testing kits to ensure accuracy and reliability. In addition to its consumer-facing service, Thriva has developed a B2B offering called Thriva Solutions, which provides diagnostic testing capabilities to other healthcare providers and businesses.

<div>
 
 AdaptHealth is a network of full-service medical equipment companies that provides tailored products and services to enable patients to live their best lives at home rather than in hospitals. The company offers a wide range of medical equipment and supplies, including CPAP machines, oxygen units, walkers, and compression socks. AdaptHealth's business model focuses on delivering healthcare solutions that fit into patients' everyday lives, with offerings that span from doctor's prescriptions to doorstep delivery.
 
 
 
 
 The company emphasizes customer service and satisfaction as its primary concern, providing online support to answer questions and a team of customer service representatives to help patients choose the right supplies. AdaptHealth also offers fast and convenient shipping directly to patients' homes. In November 2020, AdaptHealth acquired New England Home Medical Equipment (NEHME), a leading supplier of continuous glucose monitoring (CGM) and diabetes management supplies in the New England and Northeastern US. NEHME generated net revenues of approximately USD 31 million for the twelve months ended September 30, 2020, contributing to AdaptHealth's expansion in the diabetes care sector.
 
 
 
 
 Key customers and partnerships
 
 
 
 
 
 AdaptHealth serves a diverse range of patients with various medical needs, including those requiring CPAP machines for sleep apnea, oxygen therapy, mobility aids, and diabetes management supplies. The company's customer base includes individuals with chronic medical conditions who require ongoing support and medical equipment. Through its acquisition of NEHME, AdaptHealth expanded its reach to diabetes patients throughout New England and the Northeastern US.
 
</div>

AdaptHealth

DispatchHealth is a Denver-based healthcare company that provides comprehensive in-home medical care services across the US. Founded in 2013, the company aims to transform healthcare delivery by offering high-acuity care in the comfort of patients' homes. DispatchHealth's services include same-day urgent medical care, hospital alternative care, and recovery care. The company employs teams of emergency medicine and internal medicine trained professionals, including nurse practitioners, physician assistants, and emergency medical technicians, who are equipped with advanced medical tools and technologies to treat a wide range of conditions typically handled in emergency rooms or urgent care centers.
DispatchHealth's care model utilizes a proprietary technology platform that manages various aspects of the in-home care experience, including logistics, onboarding, risk stratification, care coordination, and analytics. This platform enables real-time data insights to improve patient outcomes. The company's services are designed to reduce unnecessary emergency room visits, hospital stays, and readmissions, resulting in significant cost savings for the healthcare system. As of December 2023, DispatchHealth reported treating more than one million patients across more than 30 states, leading to a 58% reduction in emergency room visits, an 8.5% 30-day hospital readmission rate, and nearly USD 1.5 billion in medical cost savings.
Key customers and partnerships
DispatchHealth has established partnerships with various healthcare stakeholders, including health plans, provider groups, health systems, employers, senior living facilities, and home health organizations. In May 2023, the company announced a collaboration with Included Health to enhance virtual-to-in-home care delivery, enabling Included Health's virtual primary care clinicians to coordinate with DispatchHealth's in-home clinical services.
DispatchHealth also formed a partnership with Instacart in January 2024 to address food insecurity among patients. This collaboration allows DispatchHealth's medical professionals to provide digital food stipends, offer medically tailored shopping lists, and send food directly to patients' homes.
In the Spokane area, DispatchHealth partnered with MultiCare Health System in August 2019 to improve healthcare access for at-risk patient populations. The company works with almost all major insurance companies, including Medicare and parts of Medicaid, to reduce the cost of care significantly.

DispatchHealth

Honor Technology, Inc. is a home care company that operates a technology-enabled platform to provide care services for older adults. Founded in 2014, Honor combines local care, 24/7 support, and advanced technology through its proprietary Honor Care Platform. This platform utilizes dynamic scheduling software and machine learning to optimize caregiver-client matching based on skills, commute times, and other factors. It also assists with caregiver recruiting, training, scheduling, and performance analysis.
In August 2021, Honor acquired Home Instead, one of the largest home care providers globally. This acquisition expanded Honor's reach significantly, with the combined company representing over USD 2.1 billion in revenue as of October 2021. Honor's technology aims to improve efficiency and care quality across its network of caregivers and partner agencies.
The company offers various services through different arms of its business. Honor Expert, launched in April 2022, is an online and mobile service that connects older adults and their families with resources, tools, and services related to aging and health issues. Honor also operates the Honor Care Network, which partners with independent home care agencies to provide back-office support, technology, and operational expertise in exchange for a share of revenue.
Key customers and partnerships
Honor has established partnerships with several national companies to enhance its service offerings. As of April 2022, Honor Expert had 14 national partners, including Amazon Business, Best Buy, SelectRX, and Freshly. These partnerships aim to provide users with access to a range of products and services addressing various aging-related needs.
The company's acquisition of Home Instead significantly expanded its customer base. Home Instead operates in 12 countries and has over 600 franchised locations in the US alone. This expansion has allowed Honor to serve clients across a wider geographic area and potentially develop contracts with national insurance carriers or major health systems.
Honor also partners with independent home care agencies through its Honor Care Network. These partnerships allow smaller agencies to benefit from Honor's technology and operational capabilities while maintaining their local presence and client relationships.

Honor

Alto Pharmacy is a digital pharmacy platform founded in 2015 by former Facebook engineers Jamie Karraker and Mattieu Gamache-Asselin. The company aims to simplify the prescription process and improve medication adherence through its technology-enabled solution. Alto's platform streamlines coordination between patients, doctors, and insurance companies, offering free same-day prescription delivery, lower costs on medications, and access to pharmacist support.
Alto's services include a mobile app for patients to manage their prescriptions, set reminders, and chat with pharmacists. The company also offers Alto Connect, a mobile app for doctors' offices to streamline prescription management and communication. Alto specializes in delivering medications for various conditions, including HIV, hepatitis C, asthma, rheumatology, and cardiology, among others.
As of 2022, Alto Pharmacy operates in 13 markets across the US, including major cities like San Francisco, Los Angeles, New York, and Houston. The company has experienced rapid growth, with its annual revenue reaching USD 700 million in 2022 and projections to cross the USD 1 billion mark by the end of that year. Alto has delivered over 4 million prescriptions to hundreds of thousands of patients and claims to have provided more than USD 120 million in savings to date.

Alto Pharmacy

LetsGetChecked is a healthcare solutions company that provides at-home diagnostic testing kits and virtual care services. Founded in 2015 by Peter Foley, the company offers over 30 different health tests covering areas such as sexual health, women's health, men's health, general wellness, and Covid-19. LetsGetChecked's testing process involves customers ordering a kit online, collecting their sample at home, and mailing it back to CLIA-certified and CAP-accredited laboratories for analysis. Results are typically available within 2-5 days through a secure online portal. The company utilizes biomarkers to analyze health conditions and employs highly accurate testing methods like NAAT PCR and electrochemiluminescence arrays for certain tests. In November 2023, LetsGetChecked achieved a significant milestone when the FDA granted marketing authorization for its Simple 2 Test, the first at-home test for chlamydia and gonorrhea. The company has expanded its services to include telehealth consultations and prescription delivery, aiming to provide a comprehensive healthcare solution. LetsGetChecked operates its own manufacturing facilities and laboratories, allowing for quality control throughout the testing process. As of 2024, the company has delivered over 7 million tests and serves more than 30 markets globally.
Key customers and partnerships
LetsGetChecked has partnered with over 300 corporate customers to provide testing services and biometric screening solutions. The company has also collaborated with major retailers and healthcare providers. In 2023, LetsGetChecked announced a partnership with PatientsLikeMe (PLM), a community health network, to offer PLM members access to testing at discounted prices. Additionally, the company has worked with UnitedHealthcare, Optum, HSA Store, FSA Store, and CVS Pharmacy. LetsGetChecked's services are available nationwide in the US, the UK, and most EU countries, with co-headquarters in Dublin and New York.

LetsGetChecked

Digital platforms that connect patients with in-person medical care providers in the comfort of their homes and support care delivery

Platforms enabling healthcare providers to order in-home therapies, durable medical equipment, and provide virtual acute care services

Companies offering a full-stack of in-home medical services including health evaluations, virtual and in-person visits for a variety of needs, and care coordination by leveraging data analytics

Platforms providing accessible lab testing solutions for a range of conditions, allowing patients to conveniently perform tests in their own homes

Digital pharmacies that deliver prescription medications directly to patients' homes and platforms that help track and manage medication adherence

Solutions enabling hospitals to establish hospital-at-home programs and providing workflow management tools for home care providers

Thriva

Sources

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless